Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Therapeutic Drug Carrier Systems
IF: 2.9 5-Year IF: 3.72 SJR: 0.573 SNIP: 0.551 CiteScore™: 2.43

ISSN Print: 0743-4863
ISSN Online: 2162-660X

Volumes:
Volume 36, 2019 Volume 35, 2018 Volume 34, 2017 Volume 33, 2016 Volume 32, 2015 Volume 31, 2014 Volume 30, 2013 Volume 29, 2012 Volume 28, 2011 Volume 27, 2010 Volume 26, 2009 Volume 25, 2008 Volume 24, 2007 Volume 23, 2006 Volume 22, 2005 Volume 21, 2004 Volume 20, 2003 Volume 19, 2002 Volume 18, 2001 Volume 17, 2000 Volume 16, 1999 Volume 15, 1998 Volume 14, 1997 Volume 13, 1996 Volume 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v22.i4.10
pages 331-418

Modification of Epithelial Tight Junction Integrity to Enhance Transmucosal Absorption

Randall J. Mrsny
School of Pharmacy, Cardiff University, Redwood Building, King Edward VII Avenue, Cardiff, Wales, UK CF10 3XF

ABSTRACT

Tight junctions (TJs) located between adjacent epithelial cells restrict the movement of solutes, ions, and even water. Restriction of macromolecules by TJ structures impedes one potential route of absorption for biopharmaceutical drugs, a route known as the paracellular pathway. It is anticipated that an improved understanding of TJ structure and cellular mechanisms that regulate its function will lead to successful strategies for improved transmucosal drug absorption through the paracellular pathway. Based upon clinical correlations between TJ dysfunction and several disease states, any approach to modify TJ integrity to enhance drug absorption in this way must be tempered by an appreciation of potential safety concerns that might develop through sustained or repeated TJ alterations. This review describes a current understanding of epithelial TJ organization and examines potential methods and implications for regulated modification of TJ function for the enhanced uptake of drugs without detrimental clinical outcomes.


Articles with similar content:

Enhancement of Ocular Drug Penetration
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.16, 1999, issue 1
Junzo Nakamura, Mikiro Nakashima, Masataka Ichikawa, Takahiro Mukai, Hitoshi Sasaki, Kenzo Yamamura, Koyo Nishida
Cracking the Junction: Update on the Progress of Gastrointestinal Absorption Enhancement in the Delivery of Poorly Absorbed Drugs
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.25, 2008, issue 2
David J. Brayden, Siobhan McClean, Sam Maher, Linda Feighery
Polymeric Micelles for Delivery of Poorly Water-Soluble Compounds
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.20, 2003, issue 5
Glen S. Kwon
Transcending the Skin Barrier to Deliver Peptides and Proteins Using Active Technologies
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.29, 2012, issue 4
Haripriya Kalluri, Anushree Herwadkar, Neha Singh, Ajay K. Banga, Advait Badkar
Nonviral Vectors for In Vivo Gene Delivery: Physicochemical and Pharmacokinetic Considerations
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.14, 1997, issue 2
Ram I. Mahato, Mitsuru Hashida, Yoshinobu Takakura